SHINE Medical Technologies (Series C)
Funding Details
Awarder
Inbox
Date Award
September 3, 2020
Vertical
Nuclear Technology
Funding URL
View Funding Page
Funding Amount
$80,000,000
Company Info
Founding Year
2010
Traction
In 2014, SHINE announced the execution of Mo-99 supply agreements with GE Healthcare and Lantheus Medical Imaging. In 2015, GE Healthcare demonstrated that SHINE Mo-99 can act as a drop-in replacement for reactor-based Mo-99.
Organizations Involved
GE Healthcare, Lantheus Medical Imaging
Founders
Greg Piefer
Market
Nuclear Medicine
Location
Janesville, WI, USA
Coinvestors
Fidelity Management & Research Company
Company Description

SHINE is a nuclear technology company working to become the world's leading provider of radioisotopes for nuclear medicine. The SHINE system uses a patented, proprietary manufacturing process that offers major advantages over existing and proposed production technologies.

Links
Website
Back to HomeBack to Nuclear Technology DealsView Funding Announcement